139 related articles for article (PubMed ID: 9145036)
1. Clinical relevance of anti-HLA antibodies pre and post transplant.
Kerman RH; Orosz CG; Lorber MI
Am J Med Sci; 1997 May; 313(5):275-8. PubMed ID: 9145036
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection.
Kerman RH; Susskind B; Buelow R; Regan J; Pouletty P; Williams J; Gerolami K; Kerman DH; Katz SM; Van Buren CT; Kahan BD
Transplantation; 1996 Jul; 62(2):201-5. PubMed ID: 8755816
[TBL] [Abstract][Full Text] [Related]
4. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome.
Worthington JE; Thomas AA; Dyer PA; Martin S
Transplantation; 1998 Jan; 65(1):121-5. PubMed ID: 9448156
[TBL] [Abstract][Full Text] [Related]
5. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
6. Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay.
Lucas DP; Paparounis ML; Myers L; Hart JM; Zachary AA
Clin Diagn Lab Immunol; 1997 May; 4(3):252-7. PubMed ID: 9144358
[TBL] [Abstract][Full Text] [Related]
7. Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study.
Buelow R; Mercier I; Glanville L; Regan J; Ellingson L; Janda G; Claas F; Colombe B; Gelder F; Grosse-Wilde H
Hum Immunol; 1995 Sep; 44(1):1-11. PubMed ID: 8522449
[TBL] [Abstract][Full Text] [Related]
8. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
[TBL] [Abstract][Full Text] [Related]
9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
10. Sensitization and sensitivity: defining the unsensitized patient.
Gebel HM; Bray RA
Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
[TBL] [Abstract][Full Text] [Related]
11. Detection of HLA-specific IGG antibodies using single recombinant HLA alleles: the MonoLISA assay.
Barnardo MC; Harmer AW; Shaw OJ; Ogg GS; Bunce M; Vaughan RW; Morris PJ; Welsh KI
Transplantation; 2000 Aug; 70(3):531-6. PubMed ID: 10949199
[TBL] [Abstract][Full Text] [Related]
12. Sensitisation to swine leukocyte antigens in patients with broadly reactive HLA specific antibodies.
Oostingh GJ; Davies HF; Tang KC; Bradley JA; Taylor CJ
Am J Transplant; 2002 Mar; 2(3):267-73. PubMed ID: 12096790
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of enzyme-linked immunosorbent assay-detected IgG anti-HLA antibodies for pediatric renal allograft rejection.
Dalla Vecchia LK; Book BK; Milgrom ML; Jindal RM; Leapman SB; Filo RS; Pescovitz MD
Transplantation; 1997 Dec; 64(12):1744-7. PubMed ID: 9422414
[TBL] [Abstract][Full Text] [Related]
14. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
Schönemann C; Groth J; Leverenz S; May G
Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
[TBL] [Abstract][Full Text] [Related]
16. Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay.
Monteiro F; Buelow R; Mineiro C; Rodrigues H; Kalil J
Transplantation; 1997 Feb; 63(4):542-6. PubMed ID: 9047148
[TBL] [Abstract][Full Text] [Related]
17. Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity.
Gao B; Rong C; Porcheray F; Moore C; Girouard TC; Saidman SL; Wong W; Fu Y; Zorn E
Transplantation; 2016 Jan; 100(1):217-26. PubMed ID: 26285015
[TBL] [Abstract][Full Text] [Related]
18. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
19. Comparison between enzyme-linked immunosorbent assay and cytotoxic cross-match procedures for detecting IgG anti-donor antibodies.
Susskind B; Kerman RH; Nelson R; Gregory J; La T; Bayat A; Dang M; Van Buren C; Katz S; Kahan BD
Transplantation; 1998 Dec; 66(12):1823-6. PubMed ID: 9884282
[TBL] [Abstract][Full Text] [Related]
20. [Histocompatibility tests in a transplantation program].
de-Leo-Cervantes C
Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
